ERADICATION OF H.PYLORI: RISK ASSESSMENT AND POSSIBLE PREVENTION OF DRUG-DRUG INTERACTIONS

QR Code

ERADICATION OF H.PYLORI: RISK ASSESSMENT AND POSSIBLE PREVENTION OF DRUG-DRUG INTERACTIONS

Modern therapy, aimed at eradication of H.pylori, includes a set of antisecretory and antibacterial drugs and sometimes bismuth preparations. A feature of modern eradication schemes is the 14-day use of antibiotics, prescribed in high daily doses and selected mainly based on microorganism resistance...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. YU. Serebrova, A. B. Prokofev, M. V. Zhuravleva, G. N. Gorodetskaya, N. N. Eremenko, E. A. Smolyarchuk, D. O. Kurguzova
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	h.pylori maastricht v eradication therapy drugs interactions proton pump inhibitors bismuth preparations clarithromycin metronidazole levofloxacin rifabutin furazolidone
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/11
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Study of the effect of Helicobacter pylori bacteria on some levels of trace elements in injured patients in Samarra city
by: Hinda Tahseen Jasim, et al.
Published: (2022-12-01)

Prevalence of Helicobacter pylori infected in the Kirkuk native population and aassociated with serum ferritin and Iron levels/Iraq
by: Nadia M. Mohammad, et al.
Published: (2019-04-01)

Comparison of bismuth and concomitant therapy for H. pylori eradication: a prospective, randomized clinical trial
by: A. Oueslati, et al.
Published: (2025-12-01)

Revealing of H. pylori markers at patients with acute viral hepatitises
by: S. N. Zuevskaja, et al.
Published: (2014-09-01)

PREVALENCE OF GASTROINTESTINAL TRACT DISEASES AND EFFICACY OF ERADICATION THERAPY FOR H.PYLORI INFECTION IN CHILDREN
by: I.A. Zhdanova, et al.
Published: (2006-07-01)

Comparing Two Treatment Regimens for Helicobacter pylori Eradication: Furazolidone or Clarithromycin?
by: Shirin Rezaei, et al.
Published: (2025-07-01)

Meta-analysis of H. pylori and the gut microbiome interactions and clinical outcomes
by: Xiongjian Wu, et al.
Published: (2025-08-01)

Optimal First-line Eradication Regimens for Helicobacter pylori Infection in Patients with Clarithromycin Resistance: A Pilot Study
by: Min Woo Seo, et al.
Published: (2018-12-01)

Bismuth-containing drugs in clinical practice in the XXI century - history or a new round of possibilities?
by: V. A. Akhmedov
Published: (2024-09-01)

Efficiency of ursodeoxycholic acid in the frameworks of minimization of hepatotoxic potential of eradication therapy of Helicobacter pylori infection
by: D. N. Andreev, et al.
Published: (2021-06-01)

DIAGNOSIS AND TREATMENT OF HELICOBACTER PYLORI INFECTION: MAIN STATEMENTS OF THE MAASTRICHT V/FLORENCE CONSENSUS REPORT (2015)
by: I. V. Maev, et al.
Published: (2017-04-01)

Rational choice of eradication therapy of <i>Helicobacter pylori</i> infection
by: T. L. Lapina, et al.
Published: (2013-10-01)

Efficacy and safety of nitazoxanide based quadruple regimen as first line therapy for treating Helicobacter pylori infected naïve patients
by: Amro M Hassan, et al.
Published: (2025-06-01)

Pathogenetic Treatment of Gastritis as a Basis for the Prevention of Gastric Cancer in the Countries of the Commonwealth of Independent States: Literature Review and the Resolution of a Scientific Symposium Held in Minsk, Republic of Belarus, January, 27, 2018
by: V. T. Ivashkin, et al.
Published: (2018-09-01)

Cytoprotection of the Gastric Mucosa and Eradication Therapy of <i>Helicobacter Pylori</i> Infection: Points of Conjugation
by: A. S. Trukhmanov, et al.
Published: (2025-06-01)

Results of long-term follow-up of patients with chronic gastritis after <i>H. pylori</i> eradication
by: T. L. Lapina, et al.
Published: (2015-09-01)

The impact of Helicobacter pylori infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis
by: Alia Albush, et al.
Published: (2025-07-01)

First-Line Prescriptions and Effectiveness of <i>Helicobacter pylori</i> Eradication Treatment in Ireland over a 10-Year Period: Data from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)
by: Sinéad M. Smith, et al.
Published: (2025-07-01)

Gastro-Intestinal Tract Complications During Antithrombotic Therapy
by: E. V. Moroz, et al.
Published: (2018-07-01)

Photoactivated decontamination as an alternative method of treatment in endodontics, periodontology and gastroenterology
Published: (2020-04-01)

Benefits of Helicobacter pylori Eradication on Extragastric Diseases
by: Tae Jun Kim, et al.
Published: (2021-12-01)

A Pilot Study of Helicobacter pylori Eradication Using a Polymerase Chain Reaction-based Test for Clarithromycin Resistance
by: Yun Duk Jung, et al.
Published: (2017-12-01)

Clinical Efficacy of Gemifloxacin-containing Triple Therapy for First-line Treatment of Helicobacter pylori Infection: A Pilot Study
by: Tae Jun Kim, et al.
Published: (2017-09-01)

Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
by: Т. L. Lapina, et al.
Published: (2024-01-01)

Diagnosis and Treatment of Peptic Ulcer in Adults (Clinical Guidelines of the Russian Gastroenterological Association, Russian Society of Colorectal Surgeons and the Russian Endoscopic Society)
by: V. T. Ivashkin, et al.
Published: (2020-04-01)

Eradication of Helicobacter pylori: a prospective comparative randomized trial of standard versus optimized quadruple therapy
by: Salma Souissi, et al.
Published: (2024-12-01)

Clinical and Pharmacological Aspects of Resistance to Eradication Therapy of Helicobacter Pylori Infection
by: S. Yu. Serebrova, et al.
Published: (2020-05-01)

Potential Unnecessity of Bismuth in Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori Infection
by: Seon Woo Oh, et al.
Published: (2025-03-01)

Compliance with Helicobacter pylori eradication: modern approaches to increase in commitment and the results of own research
by: T. A. Ilchishina
Published: (2021-06-01)

The Clinical Features and Helicobacter pylori Eradication Therapy in Lymphofollicular Gastritis: A Single Center Experience
by: Hong Ju An, et al.
Published: (2016-12-01)

Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori Infection
by: Soo Yeon Choi, et al.
Published: (2023-06-01)

Efficacy and safety of bismuth quadruple regimens containing minocycline and vonoprazan for eradication of Helicobacter pylori: Real‐world evidence
by: Qiyunna He, et al.
Published: (2024-05-01)

Histopathological findings in obese patients undergoing laparoscopic sleeve gastrectomy in the Western region of Saudi Arabia
by: Samah Saharti, et al.
Published: (2025-07-01)

Eradication Rates of Clarithromycin Triple Therapy in Korea: A Systematic Review and Meta-analysis
by: Seung Joo Kang, et al.
Published: (2021-03-01)

Impact of combined fixed-dose formulations in Helicobacter pylori eradication on incidence rate of gastric cancer in Ukraine from 2014 to 2021
by: Y.O. Protas, et al.
Published: (2025-03-01)

New Approaches to Therapy of Helicobacter pylori Infection (by the Materials of the Maastricht Consensus-IV, Florence, 2010)
by: A. G. Evdokimova, et al.
Published: (2020-05-01)

Treatment of chronic inflammatory diseases among children – DRAMa helicobacteriosis
by: P. L. Tsherbakov, et al.
Published: (2005-12-01)

Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Prevalence of H. Pylori in gastric biopsy specimens with the histopathological assessment of gastric mucosa between 2015 and 2023: A cross-sectional study
by: Mohammed N Hilmi, et al.
Published: (2025-06-01)

Improving the effectiveness of eradication therapy for Helicobacter pylori infection
by: E. A. Ljaljukova, et al.
Published: (2024-12-01)